AUSTRALIA
Mesoblast Limited
Level 39
55 Collins Street
Melbourne 3000
T: +61 3 9639 6036
F: +61 3 9639 6030
E: info@mesoblast.com
UNITED STATES
Mesoblast Limited
Level 3
505 Fifth Avenue
New York, NY 10017
T: +1 212 880 2060
F: +1 212 880 2061
E: info@mesoblast.com
For media and investor inquiries, please contact:
Julie Meldrum
T: + 61 3 9639 6036
E: julie.meldrum@mesoblast.com
For business development inquiries, please contact:
Clinical trials enquiries from members of the public:
We are unable to respond to enquiries from the public about participation in our clinical trials or treatment with our products. Under Australian regulations, Mesoblast cannot advise people about their medical condition or choice of treatment. Please also note that enrollment for a clinical trial is not undertaken by Mesoblast, but by the doctors in charge of the clinical trial sites. Patients should discuss their medical condition and treatment options, including possible clinical trial participation, with their doctor.
For general information about our clinical trials, please click here. For answers to frequently asked questions on clinical trials, please click here.
Requests for general information on clinical trials not provided on this website may be sent to: clinical@mesoblast.com